Friday 6 November 2026 Export MRVI’s income statement to Excel — free account

Maravai LifeSciences Holdings, Inc.

Maravai LifeSciences Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $185.7 million, down 28.3% from fiscal 2024.

Revenue: +10.1%
EPS: +50.0%
Free cash flow: +123.9%
Total debt: −45.4%

Quarter to September 2026, against a year earlier

Insider buying

7.52 0.54 +7.74%

Follow MRVI

Alert me

Market cap: $1.8B
P/E: 0.0×
Fwd P/E: −24.4×
Dividend yield: —
F-score: 2/9
Altman Z: 0.44
Beneish M: −3.30
Dividend safety: n/a

Overview

	Older periods	Dec '25	Mar '26	Jun '26	Sep '26 From the 10-Q filed 5 Nov
Piotroski F-Score Full definition →	+8 more TTM periods Free account	2	3	5	5
ROE Full definition →		(27.53%)	(23.25%)	(18.79%)	(17.01%)
ROA Full definition →		(14.70%)	(12.50%)	(10.31%)	(9.06%)
ROIC Full definition →		(28.16%)	(22.18%)	(15.83%)	(13.62%)
Return on Tangible Assets Full definition →		(32.46%)	(29.37%)	(29.80%)	(25.59%)
Average Days of Receivables Full definition →		50.11	59.57	54.44	44.06
Free Cash Flow per Share Full definition →		(0.49)	(0.36)	(0.24)	(0.08)
Free Cash Flow Full definition →		(70.72)	(52.60)	(35.84)	(12.54)
Capital Expenditures Full definition →		(13.15)	(13.08)	(10.58)	(7.44)
Other line items
Cash ROIC Full definition →		(7.76%)	(6.53%)	(5.95%)	(2.13%)
Accounts Receivable Turnover Full definition →		5.80	6.61	7.07	8.83
Accounts Payable Turnover Full definition →		20.41	16.03	14.58	17.90
Inventory Turnover Full definition →		3.35	3.21	3.09	2.93
Average Days of Payables Full definition →		7.00	21.52	19.13	18.26
Days of Inventory on Hand Full definition →		97.40	102.02	110.71	121.79
Tax Rate Full definition →		(0.02)	(0.02)	0.00	0.00
Research and Development Expense of Revenue Full definition →		9.37%	8.01%	7.29%	6.93%
Selling, General and Administrative Expense of Revenue Full definition →		78.13%	65.77%	61.31%	57.80%
Share Based Compensation of Revenue Full definition →		16.25%	12.95%	14.34%	14.55%
Interest Coverage Full definition →		(7.98)	(6.48)	(4.89)	(4.57)
Operating CF/Net income Full definition →		0.44	0.38	0.33	0.08
Depreciation/Fixed assets Full definition →		0.41	0.41	0.41	0.00
Capex/Depreciation Full definition →		(0.21)	(0.22)	(0.18)	0.00
Revenue per Share Full definition →		1.29	1.40	1.41	1.43
Operating CF per Share Full definition →		(0.40)	(0.27)	(0.17)	(0.03)
Capex per Share Full definition →		(0.09)	(0.09)	(0.07)	(0.05)
Capex to Sales Full definition →		0.07	0.06	0.05	0.03

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026

Stockrow Weekly